Vincent Y. W. Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vincent Y. W. Lin has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
Joseph M. Chen
Department of Otolaryngology Head & Neck Surgery, Sunnybrook Health Sciences Centre University of Toronto Toronto Ontario Canada
8 shared publications- Joseph M. Chen
Department of Otolaryngology–Head and Neck Surgery Sunnybrook Health Sciences Centre, University of Toronto Toronto Ontario Canada
8 shared publications - Jennifer Lee Spiegel
Department of Otolaryngology Head and Neck Surgery Sunnybrook Health Sciences Centre, University of Toronto Toronto Ontario Canada
6 shared publications Trung N. Le
Department of Otolaryngology Head & Neck Surgery, Sunnybrook Health Sciences Centre University of Toronto Toronto Ontario Canada
6 shared publicationsJulian M. Nedzelski
Department of Otolaryngology–Head and Neck Surgery Sunnybrook Health Sciences Centre Toronto Ontario Canada
4 shared publications- Amr F. Hamour
Department of Otolaryngology – Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
3 shared publications
Latest Publications
- Open Access
- 23 December 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (6) , 2708-2718
Adjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?
Objectives: The pathophysiology of sudden sensorineural hearing loss (SSNHL) is still unknown, and therefore treatment strategies are often debated. Traditionally, SSNHL is treated with steroids, either orally (OCS) and/or via intratympanic injection (ITSI). Hyperbaric oxygen treatment (HBOT) has resurged in popularity as an adjunctive therapy. The present study investigated the additive effect of HBOT to traditional steroid treatment for SSNHL. Methods: Retrospective study comparing treatment effect (pure tone average–PTA; speech recognition threshold–SRT; word recognition score–WRS) between HBOT + ITSI and ITSI treated patients. Sub‐analysis of responders and nonresponders, treatment delay, and number of injection/dives. Results: One hundred nineteen patients were divided into ITSI ( n = 73) and HBOT + ITSI ( n = 46) groups. While there was a significant pre‐to‐posttreatment improvement in PTA, SRT, and WRS ( p < 0.001) within each group, there was no difference between groups in pre‐to‐postimprovement for PTA, SRT, or WRS ( p = 0.49, 0.07, or 0.55, respectively). Of responders to treatment, 4.1% did not receive OCS compared to 24.4% of nonresponders ( p < 0.001). In HBOT responders, audiogram improvement was demonstrated within 10.9 ± 6.5 (max 23) sessions. 25.8% of HBOT responders showed no response after completing ITSI and then subsequently demonstrated audiometric response after 17.5 ± 4.0 HBOT dives. Conclusion: No additional treatment benefit was found with adjunctive concurrent HBOT. HBOT might be of value to patients refractory to steroid treatment. No beneficial treatment effect in receiving more than 23 HBOT dives was observed. However, evaluating treatment effect in SSNHL loss is always biased by the well‐known confounders that are linked to the condition. Level of Evidence: 3
- 23 December 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (6) , 2708-2718
Open AccessAdjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?
Objectives: The pathophysiology of sudden sensorineural hearing loss (SSNHL) is still unknown, and therefore treatment strategies are often debated. Traditionally, SSNHL is treated with steroids, either orally (OCS) and/or via intratympanic injection (ITSI). Hyperbaric oxygen treatment (HBOT) has resurged in popularity as an adjunctive therapy. The present study investigated the additive effect of HBOT to traditional steroid treatment for SSNHL. Methods: Retrospective study comparing treatment effect (pure tone average–PTA; speech recognition threshold–SRT; word recognition score–WRS) between HBOT + ITSI and ITSI treated patients. Sub‐analysis of responders and nonresponders, treatment delay, and number of injection/dives. Results: One hundred nineteen patients were divided into ITSI ( n = 73) and HBOT + ITSI ( n = 46) groups. While there was a significant pre‐to‐posttreatment improvement in PTA, SRT, and WRS ( p < 0.001) within each group, there was no difference between groups in pre‐to‐postimprovement for PTA, SRT, or WRS ( p = 0.49, 0.07, or 0.55, respectively). Of responders to treatment, 4.1% did not receive OCS compared to 24.4% of nonresponders ( p < 0.001). In HBOT responders, audiogram improvement was demonstrated within 10.9 ± 6.5 (max 23) sessions. 25.8% of HBOT responders showed no response after completing ITSI and then subsequently demonstrated audiometric response after 17.5 ± 4.0 HBOT dives. Conclusion: No additional treatment benefit was found with adjunctive concurrent HBOT. HBOT might be of value to patients refractory to steroid treatment. No beneficial treatment effect in receiving more than 23 HBOT dives was observed. However, evaluating treatment effect in SSNHL loss is always biased by the well‐known confounders that are linked to the condition. Level of Evidence: 3
- Open Access
- 11 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Revealing heterogeneity and damage response in the adult human utricle
The human utricle is a vestibular organ essential for balance, a function that declines with age. With the aging population projected to double to 2 billion by 2050 and no pharmaceutical or biological treatments available, balance disorders represent a significant unmet medical need. The utricle is composed of sensory and non-sensory cells, which are closely related. Non-sensory cells have limited capacity to regenerate sensory cells and, therefore, are a relevant therapeutic target. In this work, we profile the cellular and transcriptional landscape of the adult human utricle and its early response to ototoxic damage using bulk and single-cell RNA-sequencing of patient-derived samples. We identify six transcriptionally distinct non-sensory cell types, including a previously uncharacterized supporting cell-like population, demonstrating utricular heterogeneity. Following aminoglycoside-induced damage, we detect early transcriptional changes consistent with a capacity to respond to ototoxic damage within 24 hours and potentially initiate a regenerative response via an early-responding cell population, providing a foundation for regenerative strategies for balance recovery.
- 11 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessRevealing heterogeneity and damage response in the adult human utricle
The human utricle is a vestibular organ essential for balance, a function that declines with age. With the aging population projected to double to 2 billion by 2050 and no pharmaceutical or biological treatments available, balance disorders represent a significant unmet medical need. The utricle is composed of sensory and non-sensory cells, which are closely related. Non-sensory cells have limited capacity to regenerate sensory cells and, therefore, are a relevant therapeutic target. In this work, we profile the cellular and transcriptional landscape of the adult human utricle and its early response to ototoxic damage using bulk and single-cell RNA-sequencing of patient-derived samples. We identify six transcriptionally distinct non-sensory cell types, including a previously uncharacterized supporting cell-like population, demonstrating utricular heterogeneity. Following aminoglycoside-induced damage, we detect early transcriptional changes consistent with a capacity to respond to ototoxic damage within 24 hours and potentially initiate a regenerative response via an early-responding cell population, providing a foundation for regenerative strategies for balance recovery.
- Open Access
- 19 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3867-3876
Synchrotron‐Based Trauma Assessment of Robotic Electrode Insertions in Cochlear Implantation
Objectives: Minimizing intraoperative trauma during cochlear implant electrode insertion is crucial for preserving residual hearing. Manual insertions are subject to variability due to surgeon experience and anatomical differences, often leading to inconsistent outcomes. Robotic‐assisted systems have been developed to improve insertion precision and reduce trauma. This study evaluates the safety and efficacy of the OTODRIVE system for cochlear implant electrode insertion.Methods: Fifteen cadaveric human temporal bones were implanted with a variety of electrodes (FLEX26, FLEX28, FLEXSOFT, FLEX34) and an inner ear catheter (INCAT). The OTODRIVE system was used to maintain a constant insertion speed of 0.1 mm/s. The samples were subsequently imaged using synchrotron radiation phase‐contrast imaging (SR‐PCI) to assess intracochlear trauma. Parameters such as linear and angular insertion depths and cochlear coverage were measured. The presence of trauma was analyzed using a trauma evaluation plot.Results: The average linear insertion depth was 24.8 ± 3.5 mm, and the average angular insertion depth was 527° ± 81°. Cochlear coverage was 74% ± 7%. Only one case of partial scala media translocation and two cases of basilar membrane elevation were observed, with no instances of severe trauma such as tip fold‐over, scala vestibuli translocation, or osseous spiral lamina fracture.Conclusion: The findings indicate that the OTODRIVE system enables consistent and controlled electrode placement while minimizing trauma to cochlear structures, suggesting its potential to enhance hearing and structural preservation outcomes. Further clinical studies are required to establish the long‐term benefits of robotic‐assisted techniques over manual insertions in routine cochlear implantation.Level of Evidence: N/A.
- 19 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3867-3876
Open AccessSynchrotron‐Based Trauma Assessment of Robotic Electrode Insertions in Cochlear Implantation
Objectives: Minimizing intraoperative trauma during cochlear implant electrode insertion is crucial for preserving residual hearing. Manual insertions are subject to variability due to surgeon experience and anatomical differences, often leading to inconsistent outcomes. Robotic‐assisted systems have been developed to improve insertion precision and reduce trauma. This study evaluates the safety and efficacy of the OTODRIVE system for cochlear implant electrode insertion.Methods: Fifteen cadaveric human temporal bones were implanted with a variety of electrodes (FLEX26, FLEX28, FLEXSOFT, FLEX34) and an inner ear catheter (INCAT). The OTODRIVE system was used to maintain a constant insertion speed of 0.1 mm/s. The samples were subsequently imaged using synchrotron radiation phase‐contrast imaging (SR‐PCI) to assess intracochlear trauma. Parameters such as linear and angular insertion depths and cochlear coverage were measured. The presence of trauma was analyzed using a trauma evaluation plot.Results: The average linear insertion depth was 24.8 ± 3.5 mm, and the average angular insertion depth was 527° ± 81°. Cochlear coverage was 74% ± 7%. Only one case of partial scala media translocation and two cases of basilar membrane elevation were observed, with no instances of severe trauma such as tip fold‐over, scala vestibuli translocation, or osseous spiral lamina fracture.Conclusion: The findings indicate that the OTODRIVE system enables consistent and controlled electrode placement while minimizing trauma to cochlear structures, suggesting its potential to enhance hearing and structural preservation outcomes. Further clinical studies are required to establish the long‐term benefits of robotic‐assisted techniques over manual insertions in routine cochlear implantation.Level of Evidence: N/A.
- Open Access
- 12 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3877-3884
Cost Benefit and Carbon Emission Saving Analysis of Remote Cochlear Implant Programming
Objective: To assess the financial benefits and carbon emission savings associated with performing virtual‐synchronous remote programming and troubleshooting following cochlear implant (CI) placement for patients who live in remote regions.Methods: CI users living ≥ 100 km from the implant center with ≥ 1 month CI experience were included. Participants were either assigned to home visits using a portable laptop (Remote Laptop; n = 20) or attended visits through the nearest Remote Hosted Site (n = 34). Direct costs in Canadian dollars from a Ministry of Health perspective and carbon emissions were compared between remote and in‐person appointments at the implant center.Results: Median distances between participants' homes to the implant center were 574 km (Remote Laptop) and 999 km (Remote Hosted Site). Average costs for both groups of remote care were lower compared with in‐person appointments at the implant center (Remote Laptop: $180.70 vs. $431.61, p = 0.002; Remote Hosted Site: $155.34 vs. $1110.89, p < 0.001). Total cost reductions were $5018.23 and $32,488.76 with cost‐to‐benefit ratios of 2.39 and 7.15 for Remote Laptop and Remote Hosted Site groups, respectively. Net carbon emission benefits were 2200.00 kg and 5691.50 kg with net carbon benefit ratios of 512.63 and 5.25 for Remote Laptop and Remote Hosted Site, respectively.Conclusion: Virtual synchronous remote CI programming and troubleshooting generates cost savings in post‐surgical care. Additionally, it achieves remarkable carbon emissions savings. More widespread adoption is expected, especially for those who reside far from implant centers.
- 12 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3877-3884
Open AccessCost Benefit and Carbon Emission Saving Analysis of Remote Cochlear Implant Programming
Objective: To assess the financial benefits and carbon emission savings associated with performing virtual‐synchronous remote programming and troubleshooting following cochlear implant (CI) placement for patients who live in remote regions.Methods: CI users living ≥ 100 km from the implant center with ≥ 1 month CI experience were included. Participants were either assigned to home visits using a portable laptop (Remote Laptop; n = 20) or attended visits through the nearest Remote Hosted Site (n = 34). Direct costs in Canadian dollars from a Ministry of Health perspective and carbon emissions were compared between remote and in‐person appointments at the implant center.Results: Median distances between participants' homes to the implant center were 574 km (Remote Laptop) and 999 km (Remote Hosted Site). Average costs for both groups of remote care were lower compared with in‐person appointments at the implant center (Remote Laptop: $180.70 vs. $431.61, p = 0.002; Remote Hosted Site: $155.34 vs. $1110.89, p < 0.001). Total cost reductions were $5018.23 and $32,488.76 with cost‐to‐benefit ratios of 2.39 and 7.15 for Remote Laptop and Remote Hosted Site groups, respectively. Net carbon emission benefits were 2200.00 kg and 5691.50 kg with net carbon benefit ratios of 512.63 and 5.25 for Remote Laptop and Remote Hosted Site, respectively.Conclusion: Virtual synchronous remote CI programming and troubleshooting generates cost savings in post‐surgical care. Additionally, it achieves remarkable carbon emissions savings. More widespread adoption is expected, especially for those who reside far from implant centers.
- Open Access
- 10 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (7) , 2564-2573
The 3D ‐Robotic Exoscope Compared With the Microscope in Cochlear Implant and Translabyrinthine Surgery
Objectives: The three‐dimensional (3D) exoscope is an innovative viewing platform in microsurgery with the potential of offering improved ergonomics and surgical performance. This study systematically evaluated the ergonomic characteristics, visualization, and subjective performance of an exoscope system compared to the microscope in cochlear implantation (CI) and translabyrinthine resection of vestibular schwannomas (VS). Methods: This prospective qualitative study was performed at a tertiary referral center. Ergonomics were evaluated subjectively with questionnaires in addition to the Rapid Upper Limb Assessment Tool (RULA), which was used as a quantitative measure of ergonomic risk. Performance and visualization parameters were assessed at specific surgical milestones in comparing the exoscope to the microscope. Results: Ergonomically, exoscopic surgery led to less straining in both subjective ( p < 0.001) and objective ( p < 0.001) measures. Visualization in terms of expansiveness, visual clarity, and depth was superior at each surgical milestone in VS (exoscope n = 7; microscope n = 5) and most of the CI milestones (exoscope n = 24; microscope n = 22). CI surgeries were completed faster with the exoscope ( p = 0.007). Conclusion: The 3D‐exoscope afforded clear ergonomic advantages as compared with the microscope in so far as to reduce strains and potentially long‐term risks to surgeons. Additional advantages over the traditional surgical microscope included improvement in the field of view and visual clarity, with no effect on time to completion. Further advancements in exoscope technology will ease the adaptation of this innovative device in cochlear implant and translabyrinthe surgeries. Level of Evidence: 3.
- 10 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (7) , 2564-2573
Open AccessThe 3D ‐Robotic Exoscope Compared With the Microscope in Cochlear Implant and Translabyrinthine Surgery
Objectives: The three‐dimensional (3D) exoscope is an innovative viewing platform in microsurgery with the potential of offering improved ergonomics and surgical performance. This study systematically evaluated the ergonomic characteristics, visualization, and subjective performance of an exoscope system compared to the microscope in cochlear implantation (CI) and translabyrinthine resection of vestibular schwannomas (VS). Methods: This prospective qualitative study was performed at a tertiary referral center. Ergonomics were evaluated subjectively with questionnaires in addition to the Rapid Upper Limb Assessment Tool (RULA), which was used as a quantitative measure of ergonomic risk. Performance and visualization parameters were assessed at specific surgical milestones in comparing the exoscope to the microscope. Results: Ergonomically, exoscopic surgery led to less straining in both subjective ( p < 0.001) and objective ( p < 0.001) measures. Visualization in terms of expansiveness, visual clarity, and depth was superior at each surgical milestone in VS (exoscope n = 7; microscope n = 5) and most of the CI milestones (exoscope n = 24; microscope n = 22). CI surgeries were completed faster with the exoscope ( p = 0.007). Conclusion: The 3D‐exoscope afforded clear ergonomic advantages as compared with the microscope in so far as to reduce strains and potentially long‐term risks to surgeons. Additional advantages over the traditional surgical microscope included improvement in the field of view and visual clarity, with no effect on time to completion. Further advancements in exoscope technology will ease the adaptation of this innovative device in cochlear implant and translabyrinthe surgeries. Level of Evidence: 3.
- Open Access
- 14 April 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3570-3578
Generative AI in Otolaryngology Residency Personal Statement Writing: A Mixed‐Methods Analysis
Objective: Generative Artificial Intelligence (GAI) interfaces have rapidly integrated into various societal domains. Widespread accessibility of GAI for drafting personal statements poses challenges for evaluators to gauge writing ability and personal insight. This study aims to compare the quality of GAI‐generated personal statements to those written by successful applicants in OHNS residency programs, via integration of statistical and qualitative thematic analyses.Methods: Personal statements were collected from successful OHNS residency applicants. Characteristic extraction from submitted statements was used to generate GAI‐written personal statements using ChatGPT 4.0. All statements were blindly reviewed by 21 experienced evaluators on a 10‐point Likert scale of authenticity, readability, personability, and overall quality. Thematic analysis of qualitative reviewer comments was conducted to extract deeper insights into evaluators' perceptions. Quantitative results were compared using independent t‐tests, while thematic coding was performed inductively using NVivo software.Results: GAI‐generated personal statements significantly outperformed applicant‐written statements in all assessed domains, including authenticity (7.67 vs. 7.05, p = 0.002), readability (8.03 vs. 7.49, p = 0.002), personability (7.33 vs. 6.72, p = 0.004), and overall score (7.49 vs. 6.90, p = 0.005). Thematic analysis revealed that GAI statements were seen as “well‐constructed but generic,” while applicant statements were often “verbose and lacked focus.” Additionally, reviewers noted concerns regarding personal insight and engagement in AI‐generated statements.Conclusion: GAI‐generated personal statements were rated more favorably across all domains, raising critical questions about the future of personal statements in the residency application process. While AI in medical education continues to evolve, clear guidelines on its ethical use in residency applications are essential.Level of Evidence: N/A
- 14 April 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3570-3578
Open AccessGenerative AI in Otolaryngology Residency Personal Statement Writing: A Mixed‐Methods Analysis
Objective: Generative Artificial Intelligence (GAI) interfaces have rapidly integrated into various societal domains. Widespread accessibility of GAI for drafting personal statements poses challenges for evaluators to gauge writing ability and personal insight. This study aims to compare the quality of GAI‐generated personal statements to those written by successful applicants in OHNS residency programs, via integration of statistical and qualitative thematic analyses.Methods: Personal statements were collected from successful OHNS residency applicants. Characteristic extraction from submitted statements was used to generate GAI‐written personal statements using ChatGPT 4.0. All statements were blindly reviewed by 21 experienced evaluators on a 10‐point Likert scale of authenticity, readability, personability, and overall quality. Thematic analysis of qualitative reviewer comments was conducted to extract deeper insights into evaluators' perceptions. Quantitative results were compared using independent t‐tests, while thematic coding was performed inductively using NVivo software.Results: GAI‐generated personal statements significantly outperformed applicant‐written statements in all assessed domains, including authenticity (7.67 vs. 7.05, p = 0.002), readability (8.03 vs. 7.49, p = 0.002), personability (7.33 vs. 6.72, p = 0.004), and overall score (7.49 vs. 6.90, p = 0.005). Thematic analysis revealed that GAI statements were seen as “well‐constructed but generic,” while applicant statements were often “verbose and lacked focus.” Additionally, reviewers noted concerns regarding personal insight and engagement in AI‐generated statements.Conclusion: GAI‐generated personal statements were rated more favorably across all domains, raising critical questions about the future of personal statements in the residency application process. While AI in medical education continues to evolve, clear guidelines on its ethical use in residency applications are essential.Level of Evidence: N/A
- Open Access
- 20 March 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (5) , e170-e175
Deafness Progressing to Cochlear Implant Eligibility Is Eight Times More Likely in the Hypoplastic Than the Degenerative Endotype of Menière's Disease
Objective: To investigate whether one of the two recently described MD endotypes—defined by either endolymphatic sac degeneration (MD-dg patients) or hypoplasia (MD-hp patients)—is associated with an increased likelihood of undergoing CI. Study Design: Retrospective multicenter cross-sectional study. Setting: Five tertiary referral centers. Patients: CI cohort: 115 adult MD patients with a history of uni- or bilateral CI. Non-CI cohort: 72 MD patients with no CI history. All included patients matched current diagnostic criteria for definite MD. Intervention: Cochlear implantation. Main Outcome Measures: Endotype distribution (MD-dg versus MD-hp) between the CI cohort and the non-CI cohort. The endotype was determined using high-resolution CT data based on the angular trajectory of the vestibular aqueduct, following established protocols. Secondary outcomes included disease laterality, age at MD diagnosis, duration of MD, and pre-CI hearing thresholds. Results: The CI cohort included significantly more MD-hp patients than the non-CI cohort (72% versus 24%, p < 0.0001). The odds ratio of CI for an MD-hp patient relative to an MD-dg patient was 8.4 (95% confidence interval, 4.3–16.1). Pre-CI audiometric data showed no significant differences in hearing thresholds between endotypes, neither in the implanted nor in the non-implanted ear. Conclusions: The MD-hp endotype, frequently associated with bilateral disease and early-age disease onset, is strongly linked to a higher likelihood of CI. Endotyping of MD patients based on endolymphatic sac pathology can effectively stratify their risk of severe hearing loss, guiding personalized audiological follow-up and clinical decisions regarding potential CI.
- 20 March 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (5) , e170-e175
Open AccessDeafness Progressing to Cochlear Implant Eligibility Is Eight Times More Likely in the Hypoplastic Than the Degenerative Endotype of Menière's Disease
Objective: To investigate whether one of the two recently described MD endotypes—defined by either endolymphatic sac degeneration (MD-dg patients) or hypoplasia (MD-hp patients)—is associated with an increased likelihood of undergoing CI. Study Design: Retrospective multicenter cross-sectional study. Setting: Five tertiary referral centers. Patients: CI cohort: 115 adult MD patients with a history of uni- or bilateral CI. Non-CI cohort: 72 MD patients with no CI history. All included patients matched current diagnostic criteria for definite MD. Intervention: Cochlear implantation. Main Outcome Measures: Endotype distribution (MD-dg versus MD-hp) between the CI cohort and the non-CI cohort. The endotype was determined using high-resolution CT data based on the angular trajectory of the vestibular aqueduct, following established protocols. Secondary outcomes included disease laterality, age at MD diagnosis, duration of MD, and pre-CI hearing thresholds. Results: The CI cohort included significantly more MD-hp patients than the non-CI cohort (72% versus 24%, p < 0.0001). The odds ratio of CI for an MD-hp patient relative to an MD-dg patient was 8.4 (95% confidence interval, 4.3–16.1). Pre-CI audiometric data showed no significant differences in hearing thresholds between endotypes, neither in the implanted nor in the non-implanted ear. Conclusions: The MD-hp endotype, frequently associated with bilateral disease and early-age disease onset, is strongly linked to a higher likelihood of CI. Endotyping of MD patients based on endolymphatic sac pathology can effectively stratify their risk of severe hearing loss, guiding personalized audiological follow-up and clinical decisions regarding potential CI.
- 10 January 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (6) , 2787-2797
Analytical review of facial nerve palsy following SARS-CoV-2 vaccination: comprehensive assessment
Purpose The SARS-CoV-2 vaccination has reduced COVID-19 infection, though facial nerve palsy (FNP) has emerged as a notable side effect of the vaccine. We evaluated the current literature on the clinical presentation and outcomes of FNP related to COVID-19 vaccination. Methods A comprehensive search of seven databases was conducted for studies up to January 2023. We included individually reported patients on FNP following COVID-19 vaccination, while cases with co-existing neurological disorders or secondary causes of FNP were excluded. Pooled descriptive and inferential analyses were conducted, with prognostic factors evaluated through regression and Kaplan–Meier survival analysis. Results A total of 33 studies were included, with data from 52 patients who developed post-COVID-19 vaccination FNP (PV-FNP). Most cases (71%) followed mRNA vaccines, primarily occurring after the first dose and within the first week post-vaccination. Nearly all cases (98%) were unilateral, with Grade III palsy being most common. Complete recovery was achieved in 55% of patients, significantly lower than pre-pandemic rate (83%). A longer latency period was associated with a reduced likelihood of full recovery, and females experienced faster recovery compared to males. Conclusion FNP following SARS-CoV-2 vaccination tends to present as mild and unilateral, with a lower full recovery rate compared to pre-pandemic cases. Symptoms often develop within the first week after vaccination, and earlier symptom onset is associated with a higher likelihood of full recovery. Recognizing these patterns provides valuable guidance for clinicians in counseling patients about prognosis and managing follow-up care effectively.
- 10 January 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (6) , 2787-2797
Analytical review of facial nerve palsy following SARS-CoV-2 vaccination: comprehensive assessment
Purpose The SARS-CoV-2 vaccination has reduced COVID-19 infection, though facial nerve palsy (FNP) has emerged as a notable side effect of the vaccine. We evaluated the current literature on the clinical presentation and outcomes of FNP related to COVID-19 vaccination. Methods A comprehensive search of seven databases was conducted for studies up to January 2023. We included individually reported patients on FNP following COVID-19 vaccination, while cases with co-existing neurological disorders or secondary causes of FNP were excluded. Pooled descriptive and inferential analyses were conducted, with prognostic factors evaluated through regression and Kaplan–Meier survival analysis. Results A total of 33 studies were included, with data from 52 patients who developed post-COVID-19 vaccination FNP (PV-FNP). Most cases (71%) followed mRNA vaccines, primarily occurring after the first dose and within the first week post-vaccination. Nearly all cases (98%) were unilateral, with Grade III palsy being most common. Complete recovery was achieved in 55% of patients, significantly lower than pre-pandemic rate (83%). A longer latency period was associated with a reduced likelihood of full recovery, and females experienced faster recovery compared to males. Conclusion FNP following SARS-CoV-2 vaccination tends to present as mild and unilateral, with a lower full recovery rate compared to pre-pandemic cases. Symptoms often develop within the first week after vaccination, and earlier symptom onset is associated with a higher likelihood of full recovery. Recognizing these patterns provides valuable guidance for clinicians in counseling patients about prognosis and managing follow-up care effectively.
- 1 January 2023
- Published by Optica Publishing Group
- Vol. 11, CM3B.6
Exploiting Caustics for Snapshot 3D Fluorescence Imaging in Wide-field Microscopy
We present a snapshot 3D fluorescence microscopy technique that extracts depth from defocus by exploiting caustics generated when spherical aberration is intentionally introduced in a high-numerical aperture microscope. The snapshot acquisition reduces the imaging time and the risk of phototoxicity associated with scanning based methods.
- 1 January 2023
- Published by Optica Publishing Group
- Vol. 11, CM3B.6
Exploiting Caustics for Snapshot 3D Fluorescence Imaging in Wide-field Microscopy
We present a snapshot 3D fluorescence microscopy technique that extracts depth from defocus by exploiting caustics generated when spherical aberration is intentionally introduced in a high-numerical aperture microscope. The snapshot acquisition reduces the imaging time and the risk of phototoxicity associated with scanning based methods.
- 8 September 2021
- Published by Wiley in The Laryngoscope
- Vol. 132 (1) , 204-211
Pain Management Following Otological Surgery: A Prospective Study of Different Strategies
Objectives: The aim of this study was to prospectively assess pain and associated analgesic consumption after otological surgery comparing two prescription patterns. Study Design: A prospective nonrandomized consecutive cohort study. Methods: 125 adult patients undergoing ambulatory otologic surgery‐cochlear implantation and endaural middle ear surgery, were assigned (according to surgeon's preference) and prospectively studied in two arms: 1) acetaminophen 500 mg + ibuprofen 400 mg; 2) acetaminophen 500 mg + codeine 30 mg. Pain levels, medication dose, disposal patterns of opioids, and suspected side effects were evaluated. Results: All patients reported mild to moderate pain. There was a statistically significant reduction of pain from day to day, which was on average 0.26 lower than the day before. Sufficient pain control could be achieved with both drug regimens with no significant difference in pain levels. Only 50% of patients who were prescribed opioids used them. Additionally, the median tablet intake was 3 tablets while 10 to 20 tablets were prescribed. The majority of patients (97%) did not dispose of these drugs safely. Conclusion: Adequate analgesia was achieved in both arms of this study. Pain control following otologic surgery with a combination of acetaminophen and nonsteroidal anti‐inflammatory drugs is recommended unless contraindications or chronic opioid use are present. If opioids such as codeine (30 mg) are prescribed, the amount should be reduced as low as possible, such as five tablets, based on our studied population. Level of Evidence: 3 Laryngoscope , 132:204–211, 2022
- 8 September 2021
- Published by Wiley in The Laryngoscope
- Vol. 132 (1) , 204-211
Pain Management Following Otological Surgery: A Prospective Study of Different Strategies
Objectives: The aim of this study was to prospectively assess pain and associated analgesic consumption after otological surgery comparing two prescription patterns. Study Design: A prospective nonrandomized consecutive cohort study. Methods: 125 adult patients undergoing ambulatory otologic surgery‐cochlear implantation and endaural middle ear surgery, were assigned (according to surgeon's preference) and prospectively studied in two arms: 1) acetaminophen 500 mg + ibuprofen 400 mg; 2) acetaminophen 500 mg + codeine 30 mg. Pain levels, medication dose, disposal patterns of opioids, and suspected side effects were evaluated. Results: All patients reported mild to moderate pain. There was a statistically significant reduction of pain from day to day, which was on average 0.26 lower than the day before. Sufficient pain control could be achieved with both drug regimens with no significant difference in pain levels. Only 50% of patients who were prescribed opioids used them. Additionally, the median tablet intake was 3 tablets while 10 to 20 tablets were prescribed. The majority of patients (97%) did not dispose of these drugs safely. Conclusion: Adequate analgesia was achieved in both arms of this study. Pain control following otologic surgery with a combination of acetaminophen and nonsteroidal anti‐inflammatory drugs is recommended unless contraindications or chronic opioid use are present. If opioids such as codeine (30 mg) are prescribed, the amount should be reduced as low as possible, such as five tablets, based on our studied population. Level of Evidence: 3 Laryngoscope , 132:204–211, 2022